Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Icon plc (ICLR)
NASDAQ:ICLR
Holding ICLR?
Track your performance easily
ICLR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$221.20 - $347.72
Previous Close$302.45
Volume299.22K
Average Volume (3M)620.10K
Market Cap
$25.05B
Enterprise Value$28.61B
Total Cash (Recent Filing)$380.06M
Total Debt (Recent Filing)$3.94B
Price to Earnings (P/E)35.2
Beta1.48
Next Earnings
Oct 23, 2024EPS Estimate
$3.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.59
Shares Outstanding82,495,086
10 Day Avg. Volume933,535
30 Day Avg. Volume620,097
Standard Deviation0.09
R-Squared0.49
Alpha0.00118
Financial Highlights & Ratios
Price to Book (P/B)2.70
Price to Sales (P/S)2.97
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.38
Enterprise Value/Gross Profit11.92
Enterprise Value/Ebitda40.35
Forecast
1Y Price Target
$368.75Price Target Upside22.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Icon News
PremiumCompany Announcements
ICON plc CEO to Speak at Global Healthcare Event
PremiumCompany Announcements
ICON plc Welcomes New CFO Nigel Clerkin
Bulls Say, Bears Say
Bulls Say
Innovation And Customer InvestmentICLR's run of recent, strong performance should continue, buoyed by continued investment in innovation from customers with sizable and durable R&D budgets as well as ICLR's ability to be flexible in trial services offered.
Market LeadershipICLR is a market leader in the contract research organization (CRO) space, particularly the late-stage clinical space, and solidified its position with the 2021 acquisition of PRA Health for ~$12Bn.
Revenue And GrowthManagement decisively reiterated their confidence in both their FY24 guidance and long-term growth plan.
Bears Say
Financial PerformanceIcon lowered 2024 revenue guidance by ($100m) at the midpoint, citing delayed C19 trial starts and increased currency headwinds.
Market ConditionsUnderperformance was due to management commentary interpreted as a talk-down of market conditions and 2025 expectations.
Revenue GuidanceICLR provided additional color on the nature of the COVID vaccine trial delays that led to the company's reduction to revenue guidance.
---
Ownership Overview
2.27% Insiders
34.16% Mutual Funds
39.64% Other Institutional Investors
23.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICLR FAQ
What was Icon plc’s price range in the past 12 months?
Icon plc lowest stock price was $221.19 and its highest was $347.72 in the past 12 months.
What is Icon plc’s market cap?
Currently, no data Available
When is Icon plc’s upcoming earnings report date?
Icon plc’s upcoming earnings report date is Oct 23, 2024 which is in 33 days.
How were Icon plc’s earnings last quarter?
Icon plc released its earnings results on Jul 24, 2024. The company reported $3.75 earnings per share for the quarter, beating the consensus estimate of $3.682 by $0.068.
Is Icon plc overvalued?
According to Wall Street analysts Icon plc’s price is currently Undervalued.
Does Icon plc pay dividends?
Icon plc does not currently pay dividends.
What is Icon plc’s EPS estimate?
Icon plc’s EPS estimate is $3.86.
How many shares outstanding does Icon plc have?
Icon plc has 82,816,600 shares outstanding.
What happened to Icon plc’s price movement after its last earnings report?
Icon plc reported an EPS of $3.75 in its last earnings report, beating expectations of $3.682. Following the earnings report the stock price went down -5.627%.
Which hedge fund is a major shareholder of Icon plc?
Among the largest hedge funds holding Icon plc’s share is First Pacific Advisors LLC. It holds Icon plc’s shares valued at 112M.
---
Icon Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$368.75 (22.54% Upside)
$368.75 (22.54% Upside)
Blogger Sentiment
Bullish
ICLR Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 246.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.99%
12-Months-Change
Fundamentals
Return on Equity
7.77%
Trailing 12-Months
Asset Growth
-0.81%
Trailing 12-Months
Company Description
Icon plc
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
---
ICLR Company Deck
---
ICLR Earnings Call
Q2 2024
0:00 / 0:00
---
ICLR Stock 12 Month Forecast
Average Price Target
$368.75
▲(22.54% Upside)
Technical Analysis
Best Analysts Covering ICLR
1 Year
1 Year Success Rate
23/29 ratings generated profit
1 Year Average Return
+13.39%
reiterated a buy rating 2 months ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 79.31% of your transactions generating a profit, with an average return of +13.39% per trade.
---